


Uvax Bio Email Formats
Biotechnology Research • Glasgow, Delaware, United States • 1-10 Employees
Uvax Bio Email Formats
Uvax Bio uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@uvaxbio.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@uvaxbio.com | 60% |
{first name}.{last name} | john.doe@uvaxbio.com | 40% |
Key Contact at Uvax Bio
Kevin L Neill
Chief Executive Officer
Company overview
| Headquarters | 200 Biddle Ave, Unit 202, Newark, Delaware 19702, US |
| Website | |
| SIC | 873 |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
About Uvax Bio
Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform technology developed by Professor Jiang Zhu of Scripps Research to develop and commercialize B-cell focused, rapid antibody-eliciting, preventive vaccines for the most challenging diseases around the world. Our 1c-SApNP technology streamlines vaccine development and has delivered promising vaccine candidates to address global health challenges such as HIV, RSV/hMPV, PIV1-5, Ebola/Marburg, Lassa, coronaviruses including SARS-CoV, MERS-CoV and SARS-CoV-2, HCV, ZIKV/DENV, and non-viral diseases such as Malaria and Tuberculosis.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Uvax Bio has 4 employees across 3 departments.
Departments
Number of employees
Uvax Bio Tech Stack
Discover the technologies and tools that power Uvax Bio's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
JavaScript libraries
JavaScript libraries
Hosting
Analytics
Web servers
Miscellaneous
Security
JavaScript libraries
Miscellaneous
Video players
Frequently asked questions
4.8
40,000 users



